targeted delivery of mutant tolerant anti-coxsackievirus artificial micrornas using folate conjugated bacteriophage phi29 prna目标交付突变宽容anti-coxsackievirus人工使用叶酸共轭小分子核糖核酸噬菌体phi29 prna.pdfVIP

下载本文档

2
0
约10.34万字
约 22页
2017-09-12 发布于上海
举报
版权申诉

targeted delivery of mutant tolerant anti-coxsackievirus artificial micrornas using folate conjugated bacteriophage phi29 prna目标交付突变宽容anti-coxsackievirus人工使用叶酸共轭小分子核糖核酸噬菌体phi29 prna.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

targeted delivery of mutant tolerant anti-coxsackievirus artificial micrornas using folate conjugated bacteriophage phi29 prna目标交付突变宽容anti-coxsackievirus人工使用叶酸共轭小分子核糖核酸噬菌体phi29 prna

Targeted Delivery of Mutant Tolerant Anti- Coxsackievirus Artificial MicroRNAs Using Folate Conjugated Bacteriophage Phi29 pRNA Xin Ye, Zhen Liu, Maged Gomaa Hemida, Decheng Yang* Department of Pathology and Laboratory Medicine, The Institute for Heart and Lung Health, St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada Abstract Background: Myocarditis is the major heart disease in infants and young adults. It is very commonly caused by coxsackievirus B3 (CVB3) infection; however, no specific treatment or vaccine is available at present. RNA interference (RNAi)-based anti-viral therapy has shown potential to inhibit viral replication, but this strategy faces two major challenges; viral mutational escape from drug suppression and targeted delivery of the reagents to specific cell populations. Methodology/Principal Findings: In this study, we designed artificial microRNAs (AmiRs) targeting the 39untranslated region (39UTR) of CVB3 genome with mismatches to the central region of their targeting sites. Antiviral evaluation showed that AmiR-1 and AmiR-2 reduced CVB3 (Kandolf and CG strains) replication approximately 100-fold in both HeLa cells and HL-1 cardiomyoctes. To achieve specific delivery, we linked AmiRs to the folate-conjugated bacterial phage packaging RNA (pRNA) and delivered the complexes into HeLa cells, a folate receptor positive cancer cells widely used as an in vitro model for CVB3 infection, via folate-mediated specific internalization. We found that our designed pRNA-AmiRs conjugates were tolerable to target mutations and have great potential to suppress viral mutational escape with little effect on triggering interferon induction. Conclusion/Significance: This study provides important clues for designing AmiRs targeting the 3 9UT